Daily Archives: December 15, 2020
Lonsurf is approved by FDA for recurrent, metastatic gastric and gastroesophageal junction adenocarcinoma
December 15th, 2020 Cancer, Gastric cancer, TreatmentTrifluridine/tipiracil tablets (LONSURF, Taiho Pharmaceutical Co., Ltd.) were approved by the Food and Drug Administration on February 22, 2019 for adult patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma previous.... Read More
Pembrolizumab is approved by FDA for adjuvant treatment of melanoma
December 15th, 2020 Cancer, Drugs, Melanoma, TreatmentOn February 15, 2019, pembrolizumab (KEYTRUDA, Merck) was approved by the Food and Drug Administration for the adjuvant treatment of patients with melanoma with the involvement of lymph node(s) after full resection. The approval was bas.... Read More
Caplacizumab-yhdp approved by FDA
December 15th, 2020 Cancer, DrugsOn February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI, Ablynx NV) for adult patients with acquired thrombotic thrombocytopenic purpura (aTTP.... Read More
Cabozantinib is FDA-approved for hepatocellular carcinoma
December 15th, 2020 Cancer, Drugs, Liver cancer, TreatmentOn January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular carcinoma (HCC) who have previously been treated with sorafenib. The approval was based .... Read More